Editorial Board

Michael Abern, MD, Duke University Cancer Institute, United States of America 
Peter C. Albertsen, MD, MS, UConn Health,  United States of America
Emmanuel S. Antonarakis, MD, University of Minnesota Masonic Cancer Center, United States of America
Ana Aparicio, MD, University of Texas MD Anderson Cancer Center, United States of America
Riccardo Autorino, MD, PhD, Rush University, United States of America
Leslie Ballas, MD, Cedars Sinai Medical Center, United States of America
Jennifer Beebe-Dimmer MPH, PhD, Wayne State University School of Medicine & Barbara Ann Karmanos Cancer Institute, United States of America
Himisha Beltran, MD, Dana-Farber Cancer Institute, United States of America
Naeem Bhojani, MD, University of Montreal, Canada
Hannes Cash, MD, University of Magdeburg, Germany
Joseph Chin, MD, FRCSC, Western University, Canada
Felix Chun, MD, MA, FEBU, University Hospital Frankfurt, Germany
Jennifer Cullen, PhD, MPH, Case Western Reserve University, United States of America
Shin Egawa, MD, PhD, The Jikei University School of Medicine, Japan.
Ahmed M. Elshal MD, PhD, FEBU, Mansoura University, Egypt 
Nicola Fossati, PhD, University of Lugano, Italy
Giorgio Gandaglia, MD, Vita-Salute San Raffaele University, Italy
Martin Gleave, CM, MD, FRCSC, FACS, University of British Columbia, Canada
Robert J. Hamilton, MD, MPH, FRCSC, University of Toronto, Canada
Peter Hammerer, MD, PhD, Academic Hospital Braunschweig, Germany
Christopher J. Kane MD, FACS, University of California - San Diego, United States of America
Amar U. Kishan, MD, University of California, United States of America
Jun Luo, PhD, Johns Hopkins University School of Medicine, United States of America
Sachin Malde, BSc, MBBS, MSc(Urol), FRCS(Urol), Guy’s and St Thomas’ NHS Foundation Trust, United Kingdom 
Rana R. McKay, MD, University of California - San Diego, United States of America 
Kevin T. McVary, MD-FACS, Loyola University Medical Center, United States of America
Judd W. Moul MD, FACS, Duke University, United States of America
Declan G. Murphy, MB, BCh, BaO, FRCS(Urol), FRACS(Urol), Peter MacCallum Cancer Centre, Australia
Vedang Murthy, MD, DNB, Dip EPP, Tata Memorial Centre, India
Paul L. Nguyen, MD, MBA, FASTRO, Dana-Farber/Brigham Cancer Center and Harvard Medical School, United States of America
Yaw A. Nyame, MD, MS, MBA, Fred Hutchinson Cancer Center, United States of America
Jehonathan H. Pinthus MD, PhD, FRCSC, McMaster University, Canada
Guillaume Ploussard, MD, PhD, La Croix du Sud Hospital and Institut Universitaire du Cancer Toulouse Oncopole, France 
Qiang Wei, MD, Sichuan University, China
Soroush Rais-Bahrami, MD, MBA, FACS, University of Alabama at Birmingham, United States of America
Monique J. Roobol, PhD, Erasmus University Medical Centre, The Netherlands
Ashley E. Ross, MD, PhD, Northwestern Feinberg School of Medicine, United States of America
Karen Sandell Sfanos, PhD, Johns Hopkins University, United States of America
Howard I. Scher, MD, FACP, FASCO, Memorial Sloan Kettering Cancer Center, United States of America
Jeremy Teoh, FRCSEd (Urol), The Chinese University of Hong Kong, China
Martha K. Terris, MD, Medical College of Georgia, United States of America
Christian Thomas, MD, TU Dresden, Germany
Timothy C. Thompson, PhD, MD Anderson Cancer Center, United States of America
Massimo Valerio, MD, PhD, FEBU, Geneva University Hospital, Switzerland 
Geert J.L.H. van Leenders, MD, PhD, Erasmus University Medical Centre, The Netherlands
Andrea Vecchione, MD, University of Rome, Italy
Lionne D.F. Venderbos, PhD, Erasmus University Medical Center, The Netherlands. 
John W. Yaxley, MBBS(Qld), FRACS(Urol), University of Queensland, Australia
Yao Zhu, MD, Fudan University Shanghai Cancer Center, China
Thomas Zilli, MD, Oncology Institute of Southern Switzerland (IOSI), Switzerland 

Social Media Editor

Riccardo Lombardo, MD, PhD, FEBU, Sapienza University, Italy